Frontier Group Holdings, Inc. Reports Strong Financial Results Denver, Oct. 29, 2024 /PRNewswire/ Financial Highlights: Total operating revenues for the third quarter of 2024 reached $935 million, showing a 6 percent increase compared to the same period in 2023. This growth was driven by a 4 percent increase in capacity, showcasing Frontier Group Holdings, Inc.’s…
Welcome to the latest news in mental health technology! Exciting Updates from BrainsWay Ltd. BURLINGTON, Mass. and JERUSALEM, Oct. 29, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its third quarter…
Biora Therapeutics Announces Stock Offering Introduction SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that it has entered into definitive agreements for the purchase and sale of 745,342 shares of the Company’s common stock at an offering price of $4.025 per share…
CervoMed Inc. Announces Presentation of RewinD-LB Phase 2b Study Data at ILBDC Conference Topline Data Expected in December 2024 BOSTON, Oct. 29, 2024 (GLOBE NEWSWIRE) — CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company specializing in treatments for age-related neurologic disorders, has disclosed that they will be sharing detailed safety and efficacy results from the completed…
Inverite Insights Inc. Reports Rapid Adoption of Open Banking Platform Vancouver, British Columbia–(Newsfile Corp. – October 29, 2024) – Inverite Insights Inc. (CSE: INVR) (OTC Pink: INVRF) (FSE: 2V00) (“Inverite” or the “Company”), a leading AI-driven software provider utilizing real-time financial data to empower credit facilitators to transact more effectively with consumers is excited to…
Revolutionizing Diabetes Treatment: Eledon Pharmaceuticals Shares Promising Results for Tegoprubart Breakthrough in Type 1 Diabetes Patients Undergoing Islet Transplantation Diabetes has been a prevalent health issue affecting millions of people worldwide, with Type 1 Diabetes (T1D) being a particularly challenging condition to manage. However, a recent development by Eledon Pharmaceuticals has sparked hope and excitement…
Company to Present Results from Phase 1 Clinical Trial of Rhenium (186Re) Obisbemeda for Leptomeningeal Metastases AUSTIN, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company developing targeted radiotherapeutics for CNS cancers, will be presenting data at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting in Houston, Texas….
Order Represents Major Milestone in Advancing Beyond Oil’s Global Expansion Embracing a Healthier Future With the rising concerns over health risks associated with fried foods, the innovative strides taken by Beyond Oil Ltd. are nothing short of groundbreaking. By focusing on reducing these risks, the company is not only revolutionizing the food-tech industry but also…
